Sponsor:
Tenax Therapeutics, Inc.
Code:
NCT05983250
Conditions
Pulmonary Hypertension
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
TNX-103
Placebo
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Tenax Therapeutics, Inc. on 2025-03-11.